DTIC Public Document e2c3d3992b49030cff764bbf5d18b091

Document Details

Document Type
Cost Item
Publication Date
Oct 01, 2016
Source ID
e2c3d3992b49030cff764bbf5d18b091
Current Year Amount Norm
9834000
Group Name
Product Development
Name
HW S - Ebola Response Phase 2 clinical trials for TKM-Ebola targeting Guinea Variant
Performing Activity
Tekmira Pharmaceuticals Corp.
Prior Year Amount Norm
0

Related Documents